Carrico T J, Cohen I K
Plast Reconstr Surg. 1979 Sep;64(3):377-80. doi: 10.1097/00006534-197909000-00016.
Ninety-one patients who had had augmentation mammaplasties were evaluated retrospectively. The intra-implant use of steroids appeared to reduce the incidence of breast firmness--at least over the short follow-up period--but there were complications from this which appear to be dose related (mg of Solu-Medrol/100 cc saline). A long-term evaluation of such patients is desirable. Meanwhile, our limited data strongly suggest that the intra-implant use of steroids should be used only with caution as to the dose and with a careful follow-up.
对91例行隆乳术的患者进行了回顾性评估。植入物内使用类固醇似乎降低了乳房变硬的发生率——至少在短期随访期内如此——但由此产生了一些并发症，这些并发症似乎与剂量有关（每100 cc盐水中甲泼尼龙的毫克数）。对这类患者进行长期评估是很有必要的。同时，我们有限的数据强烈表明，植入物内使用类固醇时应仅谨慎控制剂量并进行仔细随访。
